UJET Launches CX Intercloud, the Contact Center Industry’s First Cloud to Cloud Failover Solution
Simultaneous Configuration Across AWS and GCP Ensures 100% Uptime and Availability for Customer Service and…
Simultaneous Configuration Across AWS and GCP Ensures 100% Uptime and Availability for Customer Service and…
Former Chief Information Officer and Current Chief Corporate Responsibility Officer of Argo AI joins CyberSaint…
KING OF PRUSSIA, Pa.–(BUSINESS WIRE)–#coCEO–MedRisk has promoted Danielle Lisenbey from President to co-CEO, effective March…
Basel, 02 March 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial…
Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul) patients with…
LAKE FOREST, Ill., March 02, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Dr. Paulson Will Lead Clinical Efforts Focused on Capricor’s Late-Stage Cell Therapy Program and its…
AUSTIN, TX and DURHAM, NC, March 02, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
HSB-1216’s active moiety in clinical pilot study produced a 71% response rate in TNBC and…
WOBURN, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the…
JERSEY CITY, N.J., March 02, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
SOLANA BEACH, Calif., March 02, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage…
– Notice of allowance received by Company’s licensor, The University of Sheffield (UK) bolsters intellectual…
SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer…
Three New Patents Covering Additional Patient Amifampridine Metabolizer Types have been Allowed and will Issue…
CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc., (NASDAQ: MRSN) a clinical-stage…
SEATTLE, March 02, 2022 (GLOBE NEWSWIRE) — Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging…
ROCKVILLE, Md., March 02, 2022 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
CAMBRIDGE, Mass. and NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
PALO ALTO, Calif. and SUZHOU, China, March 02, 2022 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc….